e-learning
resources
Munich 2006
Wednesday 06.09.2006
Interstial lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The influence of acute respiratory tract infection on the serum levels of KL-6 and SP-D in chronic interstitial pneumonia
Y. Ichikawa, M. Yasui, H. Murakami, M. Fujimura (Kanazawa, Japan)
Source:
Annual Congress 2006 - Interstial lung diseases
Session:
Interstial lung diseases
Session type:
Poster Discussion
Number:
4759
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Ichikawa, M. Yasui, H. Murakami, M. Fujimura (Kanazawa, Japan). The influence of acute respiratory tract infection on the serum levels of KL-6 and SP-D in chronic interstitial pneumonia. Eur Respir J 2006; 28: Suppl. 50, 4759
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Panel discussion on acute decompensated pulmonary hypertension
Related content which might interest you:
Elevated levels of serum SP-A in chronic eosinophilic pneumonia
Source: Eur Respir J 2001; 18: Suppl. 33, 409s
Year: 2001
The clinical significance of serum and bronchoalveoalr lavage inflammatory cytokine in patients with acute respiratory failure due to severe community-acquired pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 347s
Year: 2006
Diagnostic utility of serum KL-6 levels in acute respiratory failure with bilateral pulmonary infiltrates
Source: Virtual Congress 2020 – Experimental and laboratory studies in intensive care unit medicine
Year: 2020
KL-6 levels are elevated in plasma from patients with acute respiratory distress syndrome
Source: Eur Respir J 2004; 23: 142-145
Year: 2004
Serum KL-6 elevation related with severity in patients with pneumocystis pneumonia
Source: Annual Congress 2011 - Infection in the immunocompromised host: infrequent aetiologies
Year: 2011
Impact of bronchial airflow limitation and recent respiratory tract infection on the circulating level of C-reactive protein in an elderly population
Source: Annual Congress 2006 - Inflammation markers in community-acquired pneumonia
Year: 2006
The contribution of infection and the respiratory microbiome in acute exacerbations of idiopathic pulmonary fibrosis
Source: Eur Respir Rev, 28 (152) 190045; 10.1183/16000617.0045-2019
Year: 2019
KL-6/MUC1 in interstitial pneumonia
Source: Annual Congress 2005 - Lung-specific serum markers for interstitial lung diseases
Year: 2005
Serum procalcitonin (PCT-Q) as a diagnostic tool for bacterial lower respiratory tract infection among COPD patients with acute exacerbation
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013
Combined serum eosinophil count and procalcitonin level as a marker of bacterial infection in acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Annual changes of serum KL-6 were inversely correlated with those of respiratory function parameters in patients with nonspecific interstitial pneumonia
Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease
Year: 2010
Alterations of surfactant phospholipids in lungs with chronic recurrent respiratory chlamydial infection
Source: Annual Congress 2011 - Infection in the immunocompromised host: infrequent aetiologies
Year: 2011
Time-course of upper respiratory tract viral infection and COPD exacerbation
Source: Eur Respir J, 54 (4) 1900407; 10.1183/13993003.00407-2019
Year: 2019
Serum chitotriosidase levels in granulomatous lung disorders
Source: Annual Congress 2006 - Clinical features and disease markers of sarcoidosis
Year: 2006
IgG immunoglobulin levels and the frequency of respiratory infections in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 543s
Year: 2002
Lysozyme level and activity are decreased in the lungs of patients with idiopathic pulmonary fibrosis (IPF) and potentially contribute to increased susceptibility to pulmonary infection
Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases
Year: 2006
Usefulness of serum bird specific antibody levels in patients with interstitial pneumonia
Source: International Congress 2016 – Orphan diseases II
Year: 2016
Identification of hBD-3 in respiratory tract and serum: the increase in pneumonia
Source: Eur Respir J 2006; 27: 253-260
Year: 2006
Serum KL-6 level is increased in patients with
pneumocystis
pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 101s
Year: 2006
Viral upper respiratory infection and acute asthma exacerbation
Source: Annual Congress 2009 - Viruses and respiratory infections: prevalence and mechanisms of infection
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept